Ranbaxy Laboratories articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2013/05/23 07:59
2013/05/23 07:59
1m
Ranbaxy shares dive over 9% on bourses in morning...
Shares of Ranbaxy Laboratories on Thursday slumped by over 9 per cent in the morning trade, after its Japanese promoters blamed the company’s former Indian owners for concealing and misrepresenting...
3
RELATED
Food and Drug Administration US Department of Justice New Delhi U.S. Department of Justice FDA
MENTIONED
2013/05/23 07:59
2013/05/23 07:59
Latest videos
2013/05/23 07:59
2013/05/23 07:59
Latest from Twitter
2013/05/22 23:50
2013/05/22 23:50
6h
Nikkei set to pull back from 5-year highs on Bern...
Nikkei set to pull back from 5-1/2-year highs on Bernanke remarks Related Topics Thu May 23, 2013 12:17am BSTTOKYO, May 23 (Reuters) - Japan's Nikkei average is expected to retreat from a 5-1/2-year...
Ben Bernanke U.S. Federal Reserve CHICAGO Osaka CONGRESS
MENTIONED
2013/05/20 12:22
2013/05/20 12:22
2d
Drug company plea, settlement worth $500 million;...
A pharmaceutical manufacturer has pleaded guilty to felony charges that it distributed adulterated drugs in the United States, agreeing to pay $500 million in fines and settlement claims that are...
1
RELATED
Ranbaxy USA Inc. Douglas Gansler Anchorage federal government Food and Drug Administration
MENTIONED
2013/05/19 17:00
2013/05/19 17:00
3d
Drug manufacturing problems and malfeasance span ...
POSTED: Friday, May 17, 2013, 9:32 AM Ranbaxy Laboratories, Ltd., is an India-based pharmaceutical company with a U.S. subsidiary, Ranbaxy USA Inc., headquartered in Parsippany, N.J. Ranbaxy...
2013/05/14 11:39
2013/05/14 11:39
8d
Ranbaxy announces conclusion of previously disclo...
Ranbaxy announces conclusion of previously disclosed U.S. justice department probe Gurgaon, May 14 : Ranbaxy Laboratories Ltd. has announced that a previously disclosed investigation by the U.S....
72
RELATED
Ranbaxy USA Inc. Food and Drug Administration Washington Ranbaxy Laboratories Limited Department of Justice
MENTIONED
2013/05/14 08:51
2013/05/14 08:51
8d
Business Briefs: Dow slips on Monday as investors...
Dow slips on Monday as investors hold back The Dow slipped Monday despite new data showing Americans increased retail spending in April. But it wasn’t enough to spur money managers into the buying...
U.S. Commerce Department CVS Caremark Corp. Walgreen Co. Alec Young S&P Capital IQ
MENTIONED
2013/05/13 22:39
2013/05/13 22:39
9d
U.S. fines Sankyo-owned Indian drug giant Ranbaxy...
U.S. authorities announced Monday a $500 million fine against Indian generic pharmaceutical manufacturer Ranbaxy after it pleaded guilty to selling adulterated drugs in the United States. Ranbaxy...
2013/05/13 21:19
2013/05/13 21:19
9d
Do Generic Drugs Work as Well as Name Brands? May...
The Department of Justice just announced its largest drug safety settlement to date. Ranbaxy USA Inc., a subsidiary of Indian generic pharmaceutical manufacturer Ranbaxy Laboratories Limited, has...
Ranbaxy USA Inc. FDA Department of Justice Ranbaxy Laboratories Limited state attorney general's office
MENTIONED
2013/05/13 19:20
2013/05/13 19:20
9d
Ranbaxy to pay $500 million in US lawsuit settlem...
Generic drugmaker Ranbaxy Laboratories Ltd pleaded guilty on Monday to felony charges related to drug safety and will pay $500 million in civil and criminal fines under the settlement agreement with...
US government US Food and Drug Administration US Department of Justice Ranbaxy USA Arun Sawhney
MENTIONED
2013/05/13 17:22
2013/05/13 17:22
9d
Ranbaxy Announces Conclusion of Previously Disclo...
GURGAON, India--(BUSINESS WIRE)--Ranbaxy Laboratories Ltd. (RLL, NSE: RANBAXY, BSE: 500359) (“Ranbaxy”), today announced that a previously disclosed investigation by the U.S. Department of Justice...
Ranbaxy Laboratories Ltd. DOJ U.S. Department of Justice Gurgaon U.S. Food and Drug Administration
MENTIONED
2013/05/08 18:00
2013/05/08 18:00
14d
Ranbaxy Laboratories’ consolidated net profit plu...
Ranbaxy Laboratories reported a 89.91 per cent decline in its consolidated net profit at Rs.125.75 crore for the first quarter ended March 31, 2013, mainly on account of absence of contribution from...
20
RELATED
New Delhi Bank of Baroda Bombay Stock Exchange Union Bank Bank of India
MENTIONED
2013/05/02 12:06
2013/05/02 12:06
20d
Teva First-Quarter Profit Slides on Provigil, Gen...
Earnings excluding some costs declined to $960 million, or $1.12 a share, from $1.3 billion, or $1.47, a year earlier, the Petach Tikva, Israel-based company said in a statement today. Profit beat the...
Teva Bloomberg Industries Petach Tikva Provigil Ranbaxy Laboratories Ltd.
MENTIONED
2013/04/29 16:29
2013/04/29 16:29
23d
FDA rejects two Gilead HIV drugs as standalone pr...
The company is seeking approval for its drug elvitegravir for people with HIV, the virus that causes AIDS, who have already been treated with other products. The drug blocks the enzyme integrase which...
Gilead United States Thomson Reuters Isentress Merck & Co
MENTIONED
2013/04/26 12:40
2013/04/26 12:40
26d
Technology, consulting largest recruiters at ISB ...
Hyderabad, April 26 : Technology and consulting were the largest recruiters at the Indian School of Business (ISB), which Friday announced that its 741 students of class of 2013 participated in the...
2013/04/24 06:07
2013/04/24 06:07
29d
Novartis Profit Rises 7% on Lack of Generic Diovan
Earnings excluding some costs increased to $3.25 billion from $3.04 billion a year earlier, the Basel, Switzerland-based company said in a statement today. Analysts predicted profit of $3.12 billion,...
Novartis Bloomberg Basel Diovan Ranbaxy Laboratories Ltd.
MENTIONED
Parts of this website powered by Open Calais, a toolkit for rich semantic metadata extraction.

Huh, what is this?
Interceder is a topic search engine aggregating the latest news on any topic into a single window of information. This page has been automatically generated. To contact Interceder click here.

Privacy Statement
Your privacy is important. Interceder does not collect and keep any personal information about visitors to the site. Interceder may use third-party advertising companies to serve ads. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements on this website, other websites, and other forms of media about goods and services of interest to you.